| Ytd | 90.85% | |
| 1y | 48.02% |
| Open | 4.53 | Prev Close | 4.46 | Low | 4.45 | High | 4.57 | Mkt Cap | 2.38B |
| Vol | 568.17K | Avg Vol | 5.00M | EPS | -0.05 | P/E | N/A | Forward P/E | 29.73 |
| Beta | 2.47 | Short Ratio | 5.50 | Inst. Own | 33.93% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 4.42 | 200-d Avg | 3.24 | 1yr Est | 5.38 |
CLOV News
Clover Health Investments NASDAQ: CLOV is positioning its Medicare Advantage business to benefit fro
Tidal Investments LLC purchased a new stake in shares of Clover Health Investments, Corp. (NASDAQ: C
Clover Health Investments, Corp. (NASDAQ: CLOV - Get Free Report)'s stock price fell 6.5% during tra
U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orche
WILMINGTON, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV)
Clover Health Investments, Corp. leverages its AI-powered Clover Assistant to drive lower claims cos
Clover Health Investments (CLOV) is rated Hold, with operational execution but a cautious outlook du
Clover Health (CLOV) has delivered strong growth, profitability, and improved guidance, supporting m
Clover Health Investments NASDAQ: CLOV is positioning its Medicare Advantage model around earlier id
UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and ra
US stocks mixed on Thurs. Dow Jones down 50 pts. Motorola Solutions Inc shares up 9.5% after reporti
Clover Health Investments, Corp. (CLOV) Q2 2026 Earnings Call Transcript
Clover Health Investments NASDAQ: CLOV reported second-quarter results that showed continued Medicar
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday&
Clover Health Investments (NASDAQ:CLOV) raises FY2026 sales outlook from $2.810 billion-$2.920 billi
Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.05 per share which beat th
Business Highlights: Delivered strong second quarter 2026 GAAP Net Income alongside continued market
Clover Health (NASDAQ:CLOV) has spent years as a speculative bet on a technology-led Medicare Advant
The disposition involved 62,711 shares at a weighted average price of $4.67 per share, totaling ~$29
WILMINGTON, Del., July 22, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV)
Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a
Clover Health Investments said in a regulatory filing on Friday that it detected unusual login activ
WILMINGTON, Del., July 09, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV)
SAN FRANCISCO, July 07, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly
CEO Andrew Toy sold 313,476 shares of Common Stock for a transaction value of ~$1.67 million as of J
Elevance sued HHS and CMS, alleging unequal Medicare Star Ratings treatment cost it about $115 milli
Director Carladenise Edwards sold 67,160 shares for a transaction value of approximately ~$230,000 o
Jim Cramer endorsed Vistra, expressed caution on Fair Isaac over AI risks: "I'm not going to
https://www.sec.gov/ix?doc=/Archives/edgar/data/1801170/000180117026000153/clov-20260615.htm
UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and ra
Clover Health Investments Corp. (NASDAQ:CLOV) shares are extending yesterday's 18.9% surge Thursday,
Clover Health shares are extending Wednesday's 18.9% surge after a court-ordered Medicare upgrad
US stocks down, Dow Jones fell 150 pts on Wed. Caseys General Stores Inc (CASY) shares up 14.4% afte
On June 9, 2026, CMS informed Clover that, consistent with the Court's order, it has recalculate
Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a
Cramer criticizes Clover Health's quarterly results, recommends Amkor for semiconductor packagin
US stock futures higher, Lowe's shares fall after reporting earnings. Other stocks declining in
Clover Health Investments (NASDAQ:CLOV) affirms FY2026 sales outlook from $2.810 billion-$2.920 bill
Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.05 per share which beat th
Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physi
Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a
Counterpart Health, Inc. ("Counterpart"), a wholly owned subsidiary of Clover Health Investm
Full Year 2026 Guidance:Average Medicare Advantage membership of 154,000 - 158,000, representing 46%
Clover Health Investments (NASDAQ:CLOV) reported quarterly losses of $(0.10) per share which met the
Clover Health Investments is trading lower Tuesday afternoon after the Trump administration proposed
https://www.wsj.com/health/healthcare/trump-administration-proposes-keeping-steady-the-rates-medicar